AR102308A1 - Composición farmacéutica para usar en el tratamiento o prevención de deficiencias de vitaminas y minerales en pacientes sometidos a cirugía de bypass gástrico - Google Patents

Composición farmacéutica para usar en el tratamiento o prevención de deficiencias de vitaminas y minerales en pacientes sometidos a cirugía de bypass gástrico

Info

Publication number
AR102308A1
AR102308A1 ARP150103369A ARP150103369A AR102308A1 AR 102308 A1 AR102308 A1 AR 102308A1 AR P150103369 A ARP150103369 A AR P150103369A AR P150103369 A ARP150103369 A AR P150103369A AR 102308 A1 AR102308 A1 AR 102308A1
Authority
AR
Argentina
Prior art keywords
vitamin
pharmaceutical composition
bypass surgery
treatment
gastric bypass
Prior art date
Application number
ARP150103369A
Other languages
English (en)
Inventor
Hamer Simon
Original Assignee
Fit For Me B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52472487&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR102308(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fit For Me B V filed Critical Fit For Me B V
Publication of AR102308A1 publication Critical patent/AR102308A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pediatric Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composición farmacéutica y combinación terapéutica para usar en el tratamiento o prevención de deficiencias de vitaminas y minerales en pacientes que han sido sometidos a una cirugía de bypass gástrico, y método de tratamiento. Reivindicación 1: Una composición farmacéutica para tratar o prevenir las deficiencias de vitaminas y de minerales en aquellos pacientes que han sido sometidos a una cirugía de by pass gástrico, caracterizada porque comprende vitamina B12 o una fuente de ésta, vitamina B6 o una fuente de ésta, hierro o una fuente de este y un vehículo farmacéuticamente aceptable, donde esta composición farmacéutica se les administra a los pacientes que lo necesitan en una cantidad apropiada para que reciban una dosis diaria de entre 250 y 500 mg de vitamina B12, de entre 0,5 y 1,5 mg de vitamina B6 y de entre 50 y 150 mg de hierro.
ARP150103369A 2014-10-17 2015-10-16 Composición farmacéutica para usar en el tratamiento o prevención de deficiencias de vitaminas y minerales en pacientes sometidos a cirugía de bypass gástrico AR102308A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL2013645A NL2013645C2 (en) 2014-10-17 2014-10-17 Pharmaceutical composition for use in the treatment or prevention of vitamin and mineral deficiencies in patients which have been subjected to gastric bypass-surgery.

Publications (1)

Publication Number Publication Date
AR102308A1 true AR102308A1 (es) 2017-02-15

Family

ID=52472487

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150103369A AR102308A1 (es) 2014-10-17 2015-10-16 Composición farmacéutica para usar en el tratamiento o prevención de deficiencias de vitaminas y minerales en pacientes sometidos a cirugía de bypass gástrico

Country Status (23)

Country Link
US (1) US20170290364A1 (es)
EP (1) EP3009133B1 (es)
CN (1) CN107106601A (es)
AR (1) AR102308A1 (es)
AU (1) AU2015331035A1 (es)
BR (1) BR112017007364B1 (es)
CA (1) CA2964197A1 (es)
CL (1) CL2017000884A1 (es)
CY (1) CY1118532T1 (es)
DK (1) DK3009133T3 (es)
ES (1) ES2606200T3 (es)
HR (1) HRP20161796T1 (es)
HU (1) HUE030367T2 (es)
IL (1) IL251687B (es)
LT (1) LT3009133T (es)
MX (1) MX370436B (es)
NL (1) NL2013645C2 (es)
PL (1) PL3009133T3 (es)
PT (1) PT3009133T (es)
RS (1) RS55508B1 (es)
SI (1) SI3009133T1 (es)
SM (1) SMT201600460B (es)
WO (1) WO2016060559A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2019348B3 (en) * 2017-07-26 2019-09-05 Ams Advanced Medical Supplements B V Pharmaceutical composition for use in the treatment or prevention of vitamin deficiency and mineral deficiency in patients who have been subjected to gastric sleeve surgery
CA3027648C (en) * 2017-12-22 2023-11-21 Mantra Pharma Nutritional formulations and kits for bariatric individuals
WO2020242306A1 (en) * 2019-05-28 2020-12-03 Espera Supplements B.V. Pharmaceutical composition for treatment of vitamin deficiencies and mineral deficiencies after pancreaticoduodenectomy
CN111513322A (zh) * 2020-05-29 2020-08-11 成都尚医信息科技有限公司 一种用于减重术后病人的流质食品及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050032741A1 (en) * 2003-08-06 2005-02-10 Balaji Venkataraman Vitamin Compositions
CN101401644A (zh) * 2008-10-08 2009-04-08 北京冠五洲生物科学研究院 用于预防出生缺陷和改善记忆的药物组合物
US20100227001A1 (en) * 2009-03-05 2010-09-09 Silvia Demeter Method of delivering nutrients

Also Published As

Publication number Publication date
US20170290364A1 (en) 2017-10-12
CL2017000884A1 (es) 2018-01-05
MX2017004723A (es) 2017-11-30
BR112017007364B1 (pt) 2021-12-14
BR112017007364A2 (pt) 2017-12-19
EP3009133A1 (en) 2016-04-20
WO2016060559A1 (en) 2016-04-21
CN107106601A (zh) 2017-08-29
DK3009133T3 (en) 2016-12-19
ES2606200T3 (es) 2017-03-23
IL251687A0 (en) 2017-06-29
EP3009133B1 (en) 2016-10-05
MX370436B (es) 2019-12-13
HRP20161796T1 (hr) 2017-03-24
LT3009133T (lt) 2017-03-10
SMT201600460B (it) 2017-03-08
CA2964197A1 (en) 2016-04-21
PL3009133T3 (pl) 2017-07-31
SI3009133T1 (sl) 2017-04-26
CY1118532T1 (el) 2017-07-12
NL2013645C2 (en) 2015-06-11
PT3009133T (pt) 2016-12-27
HUE030367T2 (en) 2017-05-29
IL251687B (en) 2020-03-31
RS55508B1 (sr) 2017-05-31
AU2015331035A1 (en) 2017-04-27

Similar Documents

Publication Publication Date Title
PE20190338A1 (es) Metodos de tratamiento de trastornos del desarrollo con gaboxadol
MX2016015434A (es) Combinaciones farmaceuticas para tratar cancer.
MX2022003072A (es) Uso de pridopidina para el tratamiento de la disminucion funcional.
CR20180253A (es) Composiciones terapéuticas para el tratamiento del virus de unmunodeficiencia humana
PH12016502352A1 (en) Pharmaceutical composition
BR112017006272A2 (pt) composição farmacêutica para tratar colite ulcerativa.
ECSP16084317A (es) Formulaciones farmacéuticas, procesos para la preparación y métodos de uso
AR102308A1 (es) Composición farmacéutica para usar en el tratamiento o prevención de deficiencias de vitaminas y minerales en pacientes sometidos a cirugía de bypass gástrico
AR112144A1 (es) Compuestos para el tratamiento del sarcoma
AR086422A1 (es) Metodo para el tratamiento de tumores solidos avanzados, volasertib
MX2022015629A (es) Uso de vibegron para tratar vejiga sobreactiva.
CL2018002734A1 (es) Métodos de tratamiento con vitamina d
CL2019002325A1 (es) Combinaciones farmacéuticas para tratar cáncer.
MX2021001612A (es) Compuestos utiles en terapia del vih.
MX2022014792A (es) Cocristales, composiciones farmaceuticas de los mismos y metodos de tratamiento que los implican.
AR098832A1 (es) Uso de laquinimod para retrasar la progresión de la enfermedad de huntington
AR099299A1 (es) Inhibidor de la proteína de transferencia de éster de colesterilo (cetp) y composiciones farmacéuticas que comprenden dicho inhibidor para uso en el tratamiento o prevención de enfermedades cardiovasculares
SG10201809673RA (en) Treatment of androgen deprivation therapy associated symptoms
AR112229A1 (es) Composición farmacéutica para usar en el tratamiento o la prevención de deficiencias de vitaminas y deficiencias de minerales en pacientes que fueron sometidos a una cirugía de banda gástrica
ECSP19000167A (es) Métodos y composiciones para el tratamiento de la hipercalciuria y la nefrolitiasis
EA201990413A1 (ru) Способ лечения печеночной энцефалопатии
AR108792A1 (es) Composiciones que comprenden timolol
BR112018002433A2 (pt) composição farmacêutica para tratamento da enxaqueca
AR114012A1 (es) Método para proporcionar terapia de celiprolol a un paciente
UA115711U (xx) Спосіб лікування печінкової енцефалопатії у хворих з вторинним біліарним цирозом печінки

Legal Events

Date Code Title Description
FB Suspension of granting procedure